{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:57:53Z","timestamp":1783684673963,"version":"3.55.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2024.2373000","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:48:49Z","timestamp":1719550129000},"page":"897-906","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor\/ivacaftor: an assessment using linked registry data in Sweden"],"prefix":"10.1080","volume":"27","author":[{"given":"Anders","family":"Lindblad","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Institute of Clinical Science at The Sahlgrenska Academy, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle de","family":"Monestrol","sequence":"additional","affiliation":[{"name":"Stockholm Cystic Fibrosis Centre, Karolinska University Hospital, Karolinska Institutet","place":["Huddinge, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Gilljam","sequence":"additional","affiliation":[{"name":"Gothenburg CF center, Vita Str\u00e5ket 12, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Krantz","sequence":"additional","affiliation":[{"name":"Uppsala Centre for Cystic Fibrosis, Uppsala University Hospital","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"McGarry","sequence":"additional","affiliation":[{"name":"Vertex Pharmaceuticals Incorporated","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Banefelt","sequence":"additional","affiliation":[{"name":"Quantify Research","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Aldv\u00e9n","sequence":"additional","affiliation":[{"name":"Quantify Research","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30337-6"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01662"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2391-y"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60327-5"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22519"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.11.001"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes12040562"},{"key":"e_1_3_8_9_1","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2021 annual data report. Bethesda (MD); 2022."},{"key":"e_1_3_8_10_1","unstructured":"Zolin A Orenti A Jung A et\u00a0al. European Cystic Fibrosis Society Patient Registry 2021 Annual Data Report. 2023."},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100665"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.09.005"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807120"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709847"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709846"},{"key":"e_1_3_8_19_1","unstructured":"European Medicines Agency. Medicines: Cystic Fibrosis [cited 2024 February 9]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines"},{"key":"e_1_3_8_20_1","unstructured":"Vertex Announces Long-Term Access Agreement in Sweden for Cystic Fibrosis Medicine ORKAMBI\u00ae (lumacaftor\/ivacaftor). [Internet]. London; June 18. 2018. Available from: https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-long-term-access-agreement-sweden-cystic"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1178125"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-021-00154-9"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-000998"},{"key":"e_1_3_8_24_1","unstructured":"de Monestrol I Lindblad A. CF-registret \u00c5rsrapport 2019. CF-registret: ett svenskt kvalitetsregister. 2019."},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S162021"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"e_1_3_8_27_1","unstructured":"Skatteverket. 2019 Arbetsgivaravgifter (General payroll tax) [cited 2024 Feb 9]. Available from: https:\/\/skatteverket.se\/foretagochorganisationer\/arbetsgivare\/arbetsgivaravgifterochskatteavdrag\/arbetsgivaravgifter.4.233f91f71260075abe8800020817.html"},{"key":"e_1_3_8_28_1","unstructured":"Statistics Sweden. Statistikdatabasen - Genomsnittlig m\u00e5nadsl\u00f6n kronor efter utbildningsgrupp SUN 2000 k\u00f6n och \u00e5r (Average monthly salary); 2019 [cited 2024 Feb 9]. Available from: https:\/\/www.statistikdatabasen.scb.se\/pxweb\/sv\/ssd\/START__AM__AM0110__AM0110C\/LonUtbKon\/table\/tableViewLayout1\/"},{"key":"e_1_3_8_29_1","unstructured":"Sveriges Riksbank. \u00c5rsgenomsnitt valutakurser (ackumulerat) (Annual average exchange rates); 2020. Available from: https:\/\/www.riksbank.se\/sv\/statistik\/sok-rantor\u2013valutakurser\/arsgenomsnitt-valutakurser\/?y=2020&m=12&s=Comma&f=y"},{"key":"e_1_3_8_30_1","unstructured":"Sveriges Kommuner och Regioner. Kostnad per patient (KPP): Retrospektiva DRG-vikter Somatisk v\u00e5rd 2012-2022; 2023 [cited 2024 Feb 9]. Available from: https:\/\/skr.se\/download\/18.737db4ca18beb8381802ef8\/1700486868583\/Retrospektiva%20DRGvikter%20Somatisk%20v%C3%A5rd%202012-2022.xlsx"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1361"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221086416"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-1061-3"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00797-2"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30517-8"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30215-1"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"e_1_3_8_38_1","unstructured":"Orenti Zolin Jung AAA. 2022. ECFSPR Annual Report."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2373000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:38:49Z","timestamp":1772779129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2373000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2373000"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2373000","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}